An observational study in Weaning From Mechanical Ventilation, Weaning Failure and Weaning From Mechanical Ventilation, Extubation, sponsored by Hospital do Coracao. Recruiting at 1 site in Brazil. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-23.
Sponsored by Hospital do Coracao · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This is a prospective observational study to be conducted in intensive care units of Global South countries. Patients on mechanical ventilation for more than 12 hours who have initiated the weaning process and for whom the attending team plans extubation within the next 6 hours will be included. Data will be collected for each patient during the first 7 days after extubation, with follow-up until hospital discharge or death. We plan to conduct the study in intensive care units from Global South countries (low- and middle-income countries predominantly located in the Southern Hemisphere, though some in the Northern Hemisphere are also considered).
Hospital do Coracao is the lead sponsor of 67 studies on the registry; 14 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients receiving mechanical ventilation for more than 12 hours who are planning to undergo the first separation attempt from the invasive mechanical ventilation (as defined in the WIND Classification) in the next 6 hours or that has undergone a separation attempt less than 2 hours ago will be included.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Extubation failure within 7 days.
Defined as reintubation or death within 7 days after extubation.
Time frame: 7 days.
Extubation within 28 days.
Defined as extubation within 28 days after first separation attempt.
Time frame: 28 days.
Intensive care unit length of stay.
Defined as the number of days from the time of first separation attempt until discharge from the intensive care unit.
Time frame: At intensive care unit discharge, up to 28 days.
Hospital length of stay.
Defined as the number of days from the time of first separation attempt until discharge from the hospital.
Time frame: At hospital discharge, up to 28 days.
Reintubation or death within 28 days.
Defined as composite criterion of reintubation or death within 28 days after first separation attempt.
Time frame: 28 days.
Intensive care unit mortality.
Defined as mortality from the time of first separation attempt until discharge from the intensive care unit.
Time frame: At intensive care unit discharge, up to 28 days.
Hospital mortality.
Defined as mortality from the time of first separation attempt until discharge from the hospital.
Time frame: At hospital discharge, up to 28 days.
Number of spontaneous breathing trials.
Defined as the number of spontaneous breathing trials performed after first separation attempt.
Time frame: 28 days.
WIND classification.
Group 1 (short weaning): the first separation attempt resulted in a termination of the weaning process within 24 hours (successful separation or early death). • Group 2 (difficult weaning): weaning was terminated after more than 1 day but in less than 1 week after the first separation attempt (successful separation or death). • Group 3 (prolonged weaning): weaning was still not terminated 7 days after the first separation attempt (by success or death).
Time frame: 28 days.
Started May 2026 (actual). Primary completion is estimated for Mar 2027, 10 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hospital do Coracao